{"id":"W3202291872","doi":"10.1136/bmjdrc-2021-002484","title":"Glycemic efficacy and safety of the SGLT2 inhibitor ertugliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease: an analysis from the VERTIS CV randomized trial","year":2021,"lang":"en","type":"article","venue":"BMJ Open Diabetes Research & Care","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Pfizer","keywords":"Medicine; Kidney disease; Glycemic; Internal medicine; Type 2 diabetes; Renal function; Placebo; Glycated hemoglobin; Diabetes mellitus; Gastroenterology; Urology; Blood pressure; Endocrinology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004017951,0.0006300861,0.001952612,0.0002867786,0.0002134491,0.0008848715,0.0004587992,0.0006346046,0.00463357],"category_scores_gemma":[0.004807377,0.0002288117,0.002614606,0.0006358766,0.0005061431,0.0004601366,0.0003922162,0.001029738,0.0002669918],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006875464,"about_ca_system_score_gemma":0.0007633024,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001672151,"about_ca_topic_score_gemma":0.004007487,"domain_scores_codex":[0.9975631,0.001555473,0.0001974145,0.00025035,0.0002764565,0.0001571319],"domain_scores_gemma":[0.997294,0.001071598,0.0009394901,0.0002118554,0.0001448894,0.0003381668],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9244055,0.0006012914,0.02945963,0.001586575,0.01051113,0.0001012842,0.00005608122,0.0006093069,0.00161457,0.0001667944,0.002017548,0.02887025],"study_design_scores_gemma":[0.8180659,0.03020038,0.1302304,0.000491108,0.01489,0.0002773727,0.000088132,0.00172838,0.0007263115,0.0006520867,0.002587819,0.00006202765],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9742281,0.01873319,0.0003774852,0.0007027698,0.0002376224,0.0004832239,0.001980607,0.00004436452,0.003212706],"genre_scores_gemma":[0.9923549,0.003235791,0.0005047385,0.0005256304,0.0002180626,0.0003939437,0.002142352,0.0000108712,0.0006139039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00463357,"threshold_uncertainty_score":0.02124918,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02309952602122824,"score_gpt":0.3440394884501255,"score_spread":0.3209399624288973,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}